Guardian Pharmacy Services (NYSE:GRDN) Major Shareholder Sells $8,183,607.04 in Stock

Guardian Pharmacy Services, Inc. (NYSE:GRDN) major shareholder Equity Fund L.P. Cardinal sold 275,728 shares of the business’s stock in a transaction dated Friday, March 20th. The stock was sold at an average price of $29.68, for a total value of $8,183,607.04. Following the sale, the insider owned 345,123 shares of the company’s stock, valued at $10,243,250.64. The trade was a 44.41% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Major shareholders that own more than 10% of a company’s stock are required to disclose their transactions with the SEC.

Guardian Pharmacy Services Price Performance

Shares of NYSE GRDN opened at $34.19 on Friday. Guardian Pharmacy Services, Inc. has a 1-year low of $19.17 and a 1-year high of $38.12. The business has a 50-day moving average of $32.88 and a 200-day moving average of $29.95. The company has a market capitalization of $2.17 billion, a price-to-earnings ratio of 44.41 and a beta of 0.86.

Guardian Pharmacy Services (NYSE:GRDN) last announced its earnings results on Wednesday, March 11th. The company reported $0.37 earnings per share for the quarter, beating the consensus estimate of $0.27 by $0.10. Guardian Pharmacy Services had a return on equity of 31.64% and a net margin of 3.40%.The company had revenue of $397.62 million during the quarter, compared to the consensus estimate of $390.04 million. The firm’s quarterly revenue was up 17.4% compared to the same quarter last year. Research analysts expect that Guardian Pharmacy Services, Inc. will post 0.87 EPS for the current fiscal year.

Hedge Funds Weigh In On Guardian Pharmacy Services

Large investors have recently made changes to their positions in the business. State of Alaska Department of Revenue bought a new stake in Guardian Pharmacy Services in the 3rd quarter valued at $30,000. Ameritas Investment Partners Inc. boosted its holdings in Guardian Pharmacy Services by 26.5% during the third quarter. Ameritas Investment Partners Inc. now owns 1,647 shares of the company’s stock valued at $43,000 after purchasing an additional 345 shares in the last quarter. Raymond James Financial Inc. acquired a new stake in Guardian Pharmacy Services in the 2nd quarter valued at $43,000. Police & Firemen s Retirement System of New Jersey grew its holdings in shares of Guardian Pharmacy Services by 76.8% in the 2nd quarter. Police & Firemen s Retirement System of New Jersey now owns 2,444 shares of the company’s stock worth $52,000 after purchasing an additional 1,062 shares during the last quarter. Finally, Strs Ohio bought a new stake in Guardian Pharmacy Services during the fourth quarter worth about $75,000.

Wall Street Analysts Forecast Growth

GRDN has been the topic of several analyst reports. Stephens raised their price target on shares of Guardian Pharmacy Services from $35.00 to $36.00 and gave the company an “overweight” rating in a research note on Wednesday, January 14th. Raymond James Financial reiterated an “outperform” rating and issued a $40.00 price target on shares of Guardian Pharmacy Services in a research report on Thursday, March 12th. Truist Financial upped their price target on Guardian Pharmacy Services from $34.00 to $38.00 and gave the company a “buy” rating in a report on Thursday, March 12th. Weiss Ratings restated a “hold (c+)” rating on shares of Guardian Pharmacy Services in a report on Monday, December 29th. Finally, Zacks Research upgraded Guardian Pharmacy Services from a “hold” rating to a “strong-buy” rating in a report on Wednesday, March 18th. One equities research analyst has rated the stock with a Strong Buy rating, five have given a Buy rating and one has issued a Hold rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Buy” and a consensus price target of $38.00.

Guardian Pharmacy Services Company Profile

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company’s Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs.